[ Inside the business ]

ENVX stock analysis

ENVX · Enovix Corp

Miscellaneous electrical machinery, equipment and supplies. Growing 38%. Loses 438¢ on every dollar.

Nothing unusual in its latest filings.

The future, in 7 questions

Priced in: 2.6× sales in 5 yrs. Evidence: sales +38% · loss shrinking · Edge AI rising.

01 What's priced in?2.6× sales in 5 yrs
Sales now$39M
Needed in 5 yrs$100M
02 Is the wave rising?Edge AI · 3.2×
'20'21'22'23'24'2573
#4 of 20 mentioning it
03 Will customers keep buying?Customer D: 64% of sales
Customer D 64%Customer E 13%Everyone else
Prepaid $1MSales +38%, steady
04 Is it scarce?No
PricingBacklogPrepaidSell-outTight
05 More profit per sale?Loss shrinking: −$4.4 per $1
'23'23'24'25−$4.4
Before running costs: −275% → 19%
06 Can it fund itself?4.0 yrs of cash
05 yrs10+ yrs
Shares +10.7%/yrDebt $534M
07 What could break it?1 to watch
  • Heavy dilution

From SEC filings, price and Radar. Not advice.

The record

Early signals

Growth speeding up.

Sales growth +49%, +21%, then +38% vs. a year ago. New filings show a new major deal.

What could go wrong

Red flags.

It has moved 2.2× the market. In the 2022 rate shock it fell 33% while the market fell 24%. Debt is moderate. 1 red flag in its filings.

Speculative check

Speculative.

Speculative: operating loss, cash flowing out of operations, under $1B in sales. Cash runway: 4.0 years.

What they sell

Not broken out.

The filings don't split revenue by product in structured data.

Where each dollar goes

438¢ loss.

78¢ to make what it sells, 460¢ on research and overhead, nothing left over. Revenue $39M in the last 12 months.

Its market

1.2× the economy.

The government expects its industry, other electrical equipment and component manufacturing, to grow 2.4% a year to 2035, vs. 2.0% for the whole economy.

Market size and share

Your call.

There's no official size for its market. Enter one you trust to see its share, and slide to see what a bigger share would mean.

Life cycle

Shake-out.

Its cash flows are mixed, typical of a company in transition.

Earnings quality

Clean.

Its numbers don't resemble those of past manipulators.

Competitive advantage

0 of 6 years.

Returns beat its 6.4% cost of capital in 0 of the last 6 years. Gross margin went from 0% to 19%.

Future bets

$16M committed.

Promised to suppliers, per its latest 10-Q. Plus $106M a year on research (272% of sales).

All figures from Enovix Corp's SEC filings (EDGAR) unless tagged otherwise. Educational only, not investment advice.